SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-21-000733
Filing Date
2021-02-04
Accepted
2021-02-04 07:35:10
Documents
12
Period of Report
2021-02-04
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_020421.htm   iXBRL 8-K 27619
  Complete submission text file 0001171843-21-000733.txt   204322

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE crvs-20210204.xsd EX-101.SCH 2772
3 XBRL LABEL FILE crvs-20210204_lab.xml EX-101.LAB 34592
4 XBRL PRESENTATION FILE crvs-20210204_pre.xml EX-101.PRE 22721
5 EXTRACTED XBRL INSTANCE DOCUMENT f8k_020421_htm.xml XML 3725
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37719 | Film No.: 21588864
SIC: 2834 Pharmaceutical Preparations